Davinia Pla Selected Research

Venoms

1/2017	Proteomics and antivenomics of Papuan black snake (Pseudechis papuanus) venom with analysis of its toxicological profile and the preclinical efficacy of Australian antivenoms.
5/2015	Comparative venomics of the Prairie Rattlesnake (Crotalus viridis viridis) from Colorado: Identification of a novel pattern of ontogenetic changes in venom composition and assessment of the immunoreactivity of the commercial antivenom CroFab®.
10/2014	Combined venom gland cDNA sequencing and venomics of the New Guinea small-eyed snake, Micropechis ikaheka.
10/2014	Preclinical efficacy of Australian antivenoms against the venom of the small-eyed snake, Micropechis ikaheka, from Papua New Guinea: an antivenomics and neutralization study.
1/2014	Peptides with in vitro anti-tumor activity from the venom of the Eastern green mamba, Dendroaspis angusticeps (Elapidae).
1/2014	Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms.
4/2012	Snake venomics of Macrovipera mauritanica from Morocco, and assessment of the para-specific immunoreactivity of an experimental monospecific and a commercial antivenoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Davinia Pla Research Topics

Disease

12	Snake Bites (Snake Bite) 01/2021 - 01/2014
2	Edema (Dropsy) 01/2017 - 01/2017
2	Myotoxicity 10/2014 - 10/2014
2	Bites and Stings (Sting) 10/2014 - 04/2012
2	Atherosclerosis 01/2011 - 11/2007
1	Disseminated Intravascular Coagulation 04/2017
1	Hemolysis 01/2017
1	Adenocarcinoma of Lung 01/2014
1	Adenocarcinoma 01/2014
1	Neoplasms (Cancer) 01/2014
1	Neglected Diseases 01/2014
1	Progeria (Hutchinson Gilford Syndrome) 01/2011
1	Stroke (Strokes) 01/2011
1	Myocardial Infarction 01/2011
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 11/2007
1	Atherosclerotic Plaque (Atheroma) 11/2007
1	Hypercholesterolemia 11/2007

Drug/Important Bio-Agent (IBA)

13	Antivenins (Antivenoms)IBA 01/2021 - 04/2012
7	VenomsIBA 01/2017 - 04/2012
3	Snake Venoms (Snake Venom)IBA 01/2018 - 01/2014
2	Biological ProductsIBA 01/2019 - 01/2015
1	EnzymesIBA 01/2018
1	CoagulantsIBA 01/2017
1	Elapid Venoms (Cobra Venom)IBA 10/2014
1	Three Finger ToxinsIBA 10/2014
1	snake venom neurotoxin FIBA 01/2014
1	AntibodiesIBA 01/2014
1	Peptides (Polypeptides)IBA 01/2014
1	prelamin AIBA 01/2011
1	LaminsIBA 01/2011
1	Complement System Proteins (Complement)IBA 11/2007
1	CholesterolIBA 11/2007
1	Apolipoproteins E (ApoE)IBA 11/2007
1	ApolipoproteinsIBA 11/2007
1	Proteins (Proteins, Gene)FDA Link 11/2007
1	Messenger RNA (mRNA)IBA 11/2007

Therapy/Procedure

3	Therapeutics 06/2018 - 01/2011
1	Complementary Therapies (Alternative Medicine) 01/2018
1	Intravenous Injections 01/2017